3D mesenchymal stem cell exosome-functionalized hydrogels for corneal wound healing
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.02.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Yuehe Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, State Key Laboratory Cultivation Base,…. Hauptthemen laut MEDLINE: Hydrogels, Exosomes, Mesenchymal Stem Cells, Wound Healing. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Technology Research and Development Program of Shandong Province, Taishan Scholar Project of Shandong Province.
Themen: Wundversorgung
Abstract (Originalsprache)
Mesenchymal stem cell (MSC)-derived exosomes have the potential to sustain immune homeostasis and facilitate tissue regeneration, and those effects can be potentiated under three-dimensional (3D) cell culture conditions. Nevertheless, whether exosomes derived from 3D-cultured MSCs (3D-Exos) exert therapeutic effects on the injured corneas and the underlying mechanism remain unclear. In this study, MSCs are cultured in a gelatin methacryloyl (GelMA) hydrogel to produce 3D-Exos. In vitro experiments revealed that the 3D-cultured MSCs maintained their stemness, the exosomes were produced in better yield, and the generated 3D-Exos possess exceptional anti-inflammatory, pro-proliferative and tissue remodeling properties. Moreover, the 3D-Exos that were delivered by the GelMA hydrogel displayed a sustained release profile for multi-dimensional injured cornea repair. Extensive in vitro studies further demonstrated that, compared with the two-dimensional (2D)-Exo-hydrogel treatment, 3D-Exo-hydrogel treatment yielded better recovery of corneal morphology and function, as revealed by mitigated inflammation, promoted corneal epithelium and limbus repair, and reduced scar formation in the stroma. Mechanistically, the 3D-Exos promoted the proliferation of cornea-derived cells and reduced the release of inflammatory factors via miR-150-5p targeting of the PDCD4 gene. Overall, the developed 3D-Exo-hydrogel sustained release system may represent a promising cell-free strategy for the treatment of various corneal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, School of Ophthalmology, Sha…
- Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore.
Förderung
- National Natural Science Foundation of China
- Key Technology Research and Development Program of Shandong Province
- Taishan Scholar Project of Shandong Province
- Shandong Province Natural Science Foundation
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Xu, Y., Wei, C., Ma, L., Zhao, L., Li, D., Lin, Y., Zhou, Q., Xie, L., & Wang, F. (2025). 3D mesenchymal stem cell exosome-functionalized hydrogels for corneal wound healing. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.030
Vancouver
Xu Y, Wei C, Ma L, Zhao L, Li D, Lin Y, et al. 3D mesenchymal stem cell exosome-functionalized hydrogels for corneal wound healing. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.030
BibTeX
@article{Xu2025,
author = {Xu, Yuehe and Wei, Chao and Ma, Li and Zhao, Long and Li, Dongfang and Lin, Yiliang and Zhou, Qingjun and Xie, Lixin and Wang, Fuyan},
title = {3D mesenchymal stem cell exosome-functionalized hydrogels for corneal wound healing},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.02.030}
}
EUVIMED